BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29210673)

  • 41. Probing oligomerization of amyloid beta peptide in silico.
    Dorosh L; Stepanova M
    Mol Biosyst; 2016 Dec; 13(1):165-182. PubMed ID: 27844078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway.
    Di Carlo MG; Minicozzi V; Foderà V; Militello V; Vetri V; Morante S; Leone M
    Biophys Chem; 2015 Nov; 206():1-11. PubMed ID: 26100600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-assembled lipoprotein based gold nanoparticles for detection and photothermal disaggregation of β-amyloid aggregates.
    Martins PA; Alsaiari S; Julfakyan K; Nie Z; Khashab NM
    Chem Commun (Camb); 2017 Feb; 53(13):2102-2105. PubMed ID: 28098266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. On the Molecular Form of Amyloid Marker, Auramine O, in Human Insulin Fibrils.
    Mudliar NH; Pettiwala AM; Awasthi AA; Singh PK
    J Phys Chem B; 2016 Dec; 120(49):12474-12485. PubMed ID: 27973839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monitoring the Assembly and Aggregation of Polypeptide Materials by Time-Resolved Emission Spectra.
    Alghamdi A; Chung LHC; Rolinski OJ
    Methods Mol Biol; 2021; 2208():167-177. PubMed ID: 32856262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A discrete mathematical model for the aggregation of β-Amyloid.
    Dayeh MA; Livadiotis G; Elaydi S
    PLoS One; 2018; 13(5):e0196402. PubMed ID: 29791461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optical trapping for the characterization of amyloid-beta aggregation kinetics.
    Veloso AJ; Yoshikawa H; Cheng XR; Tamiya E; Kerman K
    Analyst; 2011 Oct; 136(20):4164-7. PubMed ID: 21874168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
    Kang MK; Lee J; Nguyen AH; Sim SJ
    Biosens Bioelectron; 2015 Oct; 72():197-204. PubMed ID: 25982728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R; Araya T; Arai T; Sohma Y; Kanai M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aggregation of Beta-Amyloid Peptides Proximal to Zwitterionic Lipid Bilayers.
    Yang CI; Tsai BN; Huang SJ; Wang TY; Tai HC; Chan JC
    Chem Asian J; 2015 Sep; 10(9):1967-71. PubMed ID: 26097047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Initial stages of beta-amyloid Aβ
    Amaro M; Kubiak-Ossowska K; Birch DJS; Rolinski OJ
    Methods Appl Fluoresc; 2013 Mar; 1(1):015006. PubMed ID: 29148438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alzheimer peptides aggregate into transient nanoglobules that nucleate fibrils.
    Luo J; Wärmländer SK; Gräslund A; Abrahams JP
    Biochemistry; 2014 Oct; 53(40):6302-8. PubMed ID: 25198136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of early stage intermediates in the nucleation phase of Aβ aggregation.
    Zhai J; Lee TH; Small DH; Aguilar MI
    Biochemistry; 2012 Feb; 51(6):1070-8. PubMed ID: 22283417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide.
    Faller P; Hureau C; Berthoumieu O
    Inorg Chem; 2013 Nov; 52(21):12193-206. PubMed ID: 23607830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein amyloids develop an intrinsic fluorescence signature during aggregation.
    Chan FT; Kaminski Schierle GS; Kumita JR; Bertoncini CW; Dobson CM; Kaminski CF
    Analyst; 2013 Apr; 138(7):2156-62. PubMed ID: 23420088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of early stages of amyloid Aβ13-23 formation using molecular dynamics simulation in implicit environments.
    Bajda M; Filipek S
    Comput Biol Chem; 2015 Jun; 56():13-8. PubMed ID: 25749181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes.
    Canale C; Seghezza S; Vilasi S; Carrotta R; Bulone D; Diaspro A; San Biagio PL; Dante S
    Biophys Chem; 2013 Dec; 182():23-9. PubMed ID: 23998637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
    Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
    Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.